Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Aclaris Therapeutics Stock News

ACRSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Aclaris Therapeutics (ACRS) Forecast

News

Earnings Aclaris Therapeutics (ACRS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Aclaris Therapeutics Stock News | NASDAQ:ACRS | Benzinga

Get the latest news on Aclaris Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Aclaris Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, June 02, 2025

Aclaris Therapeutics Has Initiated A Randomiz...
Benzinga Newsdesk

Wednesday, May 28, 2025

Aclaris Therapeutics shares are trading highe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor
Wedbush Initiates Coverage On Aclaris Therape...
Benzinga Newsdesk

Wednesday, May 14, 2025

HC Wainwright & Co. Maintains Buy on Aclaris ...
Benzinga Newsdesk

Thursday, May 08, 2025

Aclaris Therapeutics Q1 EPS $(0.12), Inline, ...
Benzinga Newsdesk

Tuesday, April 22, 2025

Aclaris shares are trading higher after the c...
Benzinga Newsdesk
Aclaris Therapeutics: FDA Clears IND Applicat...
Benzinga Newsdesk

Tuesday, March 18, 2025

Cantor Fitzgerald Reiterates Overweight on Ac...
Benzinga Newsdesk

Friday, March 07, 2025

Scotiabank Initiates Coverage On Aclaris Ther...
Benzinga Newsdesk

Thursday, February 27, 2025

Aclaris Therapeutics Expects Cash Runway Into...
Benzinga Newsdesk
Aclaris Therapeutics Q4 2024 GAAP EPS $(1.01)...
Benzinga Newsdesk

Wednesday, February 12, 2025

Aclaris Therapeutics Announced The Availabili...
Benzinga Newsdesk

Monday, December 23, 2024

Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy
Anusuya Lahiri
This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
Avi Kapoor
HC Wainwright & Co. Upgrades Aclaris Therapeu...
Benzinga Newsdesk

Tuesday, November 19, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
Vandana Singh
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Leerink Partners Upgrades Aclaris Therapeutic...
Benzinga Newsdesk
Jefferies Upgrades Aclaris Therapeutics to Bu...
Benzinga Newsdesk
Aclaris Therapeutics shares are trading highe...
Benzinga Newsdesk
BTIG Upgrades Aclaris Therapeutics to Buy, An...
Benzinga Newsdesk

Monday, November 18, 2024

Piper Sandler Upgrades Aclaris Therapeutics t...
Benzinga Newsdesk
Aclaris Therapeutics Shares Spike Higher; Pip...
Benzinga Newsdesk
Aclaris Therapeutics shares are trading highe...
Benzinga Newsdesk
Aclaris Therapeutics Secures $80M Through Pri...
Benzinga Newsdesk
Aclaris Therapeutics Announces Exclusive, Glo...
Benzinga Newsdesk

Wednesday, November 06, 2024

Aclaris Had Aggregate Cash, Cash Equivalents ...
Benzinga Newsdesk
Aclaris Therapeutics Q3 2024 GAAP EPS $(0.11)...
Benzinga Newsdesk

Monday, October 28, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Friday, October 25, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Tuesday, September 17, 2024

HC Wainwright & Co. Reiterates Neutral on Acl...
Benzinga Newsdesk
Aclaris Therapeutics Doses First Patient In P...
Benzinga Newsdesk

Monday, August 19, 2024

HC Wainwright & Co. Reiterates Neutral on Acl...
Benzinga Newsdesk

Wednesday, August 07, 2024

Aclaris' Cash, Cash Equivalents And Marketabl...
Benzinga Newsdesk
Aclaris Therapeutics Q2 2024 GAAP EPS $(0.15)...
Benzinga Newsdesk

Tuesday, July 23, 2024

Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor

Monday, July 22, 2024

HC Wainwright & Co. Reiterates Neutral on Acl...
Benzinga Newsdesk

Tuesday, July 16, 2024

Aclaris Therapeutics shares are trading highe...
Benzinga Newsdesk
Aclaris Therapeutics Sells OLUMIANT Royalties...
Benzinga Newsdesk

Tuesday, July 09, 2024

Is ADMA Biologics Stock Outpacing Its Medical Peers This Year?
Zacks

Monday, July 08, 2024

Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying
Avi Kapoor

Friday, June 14, 2024

$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor

Friday, May 24, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Tuesday, May 07, 2024

Aclaris Therapeutics Q1 EPS $(0.24) Beats $(0...
Benzinga Newsdesk

Monday, May 06, 2024

BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates
Zacks

Wednesday, March 06, 2024

Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved